News &amp; Updates

Partial enteral nutritional (PEN) therapy shows potential in the long-term management of mild paediatric Crohn’s disease, helping to avoid the use of corticosteroids and prevent side effects commonly observed with other inflammatory bowel disease therapies, according to a study presented at the virtual Crohn's & Colitis Congress.

Long-term PEN therapy promising in children with mild Crohn’s disease

14 Feb 2022

FOLFIRINOX safe, effective in older adults with advanced pancreatic cancer

The combination therapy of 5-fluorouracil, irinotecan, leucovorin, and oxaliplatin (FOLFIRINOX) improves response and overall survival (OS) in older adults with advanced pancreatic cancer (APC), a recent study has shown.

FOLFIRINOX safe, effective in older adults with advanced pancreatic cancer

14 Feb 2022

Vitamin D, omega 3 fatty acid supplements lower risk of autoimmune disease

Five-year supplementation with vitamin D, regardless of the presence of omega 3 fatty acids, results in a 22-percent decrease in autoimmune disease, while omega 3 fatty acid supplementation, with or without vitamin D, leads to a 15-percent reduction in autoimmune disease, results of a study have shown.

Vitamin D, omega 3 fatty acid supplements lower risk of autoimmune disease

Symptoms occur after radical prostatectomy but improve within 10 days

Symptoms commonly appear after radical prostatectomy (RP), but these significantly improve over the first 10 days, reveals a study. At the most, severe or very severe symptoms lead to just a small absolute increase in the risk of complications, which can be reassuring to patients and clinicians.

Symptoms occur after radical prostatectomy but improve within 10 days

Triplet chemo bests doublet regimen for ESCC

A triplet chemotherapeutic (CT) regimen comprising docetaxel, cisplatin, and 5-fluororacil (5-FU; DCF) outdid a doublet regimen comprising CF as neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma (ESCC), the phase III JCOG*1109 NExT study suggests.

Triplet chemo bests doublet regimen for ESCC

Delaying endoscopies due to COVID-19 safe in IBD patients

Delays in endoscopies due to the coronavirus disease 2019 (COVID-19) pandemic does not seem to worsen clinical outcomes in patients with inflammatory bowel diseases (IBD), though healthcare utilization patterns appear to be affected, according to a study reported at the recently concluded 2022 Crohn’s & Colitis Congress (CCC 2022).

Delaying endoscopies due to COVID-19 safe in IBD patients

14 Feb 2022

Caffeinated energy drinks may put kids’ health at risk

Getting a quick boost from caffeinated energy drinks at least five times per week can cause some health and behaviour problems, such as worse sleep, raised blood pressure, hyperactivity, irritation, and poorer school performance, as suggested in a study.

Caffeinated energy drinks may put kids’ health at risk

East Asia tops global lung cancer incidence and mortality

East Asia topped the world’s incidence and mortality of lung cancer in 2020, according to a global study conducted by the Chinese University of Hong Kong (CUHK) and the Association of Pacific Rim Universities (APRU).

East Asia tops global lung cancer incidence and mortality

14 Feb 2022

PD-L1 potential player in gastric adenocarcinoma

The expression of the programmed death-ligand 1 (PD-L1) is commonly upregulated in patients with gastric adenocarcinoma (GAC) and may play a role in the development of such malignancy, a recent study has found.

PD-L1 potential player in gastric adenocarcinoma

Proton beam therapy reduces dose to at-risk organs in head and neck tumours

Patients with locally advanced head and neck tumours who underwent proton beam therapy (PBT) experience significant decreases in dose to organs at risk (OAR) while maintaining comparable target coverage relative to volumetric modulated arc therapy (VMAT) treatment plans, reports a study.

Proton beam therapy reduces dose to at-risk organs in head and neck tumours